Desarrollo de un modelo in-vitro de neuronas humanas: aplicaciones biomédicas y biotecnológicas.
AB Carriquí Suárez - dspace.umh.es
En los últimos años ha surgido la necesidad de desarrollar alternativas al uso de animales
de experimentación, tanto para el testado de productos dermatológicos como para la …
de experimentación, tanto para el testado de productos dermatológicos como para la …
Nicotinamide, neural cells, and Parkinson's disease: exploring nicotinamide's effects on proliferation, neuronal differentiation, and neuroprotection within in vitro …
EL Green - 2021 - keele-repository.worktribe.com
Parkinson's disease (PD) is characterised by motor symptoms caused by degeneration of
dopaminergic neurons in the substantia nigra. The cause remains elusive and current …
dopaminergic neurons in the substantia nigra. The cause remains elusive and current …
Development of magneto-responsive hydrogel networks for neural tissue engineering
J Roe - 2021 - repository.lboro.ac.uk
Parkinsons Disease is an incurable and debilitating disease, characterised by a loss of
dopamine producing neurons in a specific area of the mid brain (substantia nigra). There is …
dopamine producing neurons in a specific area of the mid brain (substantia nigra). There is …
Regulation krankheitsassoziierter Signalwege durch differenziell exprimierte miRNAs im Parkinson-Zellkulturmodell
L Krammes - 2021 - publikationen.sulb.uni-saarland.de
Morbus Parkinson stellt eine schwerwiegende neurodegenerative Erkrankung dar, deren
Kom-plexität sowohl die Diagnosestellung als auch die Therapie bis heute erschwert. Im …
Kom-plexität sowohl die Diagnosestellung als auch die Therapie bis heute erschwert. Im …
[PDF][PDF] Establishment of an Adverse Outcome Pathway-informed testing battery for predicting Parkinsonian Motor Deficits in vitro
M Elgamal - 2020 - docserv.uni-duesseldorf.de
Parkinson's disease (PD) is the second most common neurodegenerative disorder of the
elderly affecting approximately 1% of the population older than 60 years old. Numerous …
elderly affecting approximately 1% of the population older than 60 years old. Numerous …
[PDF][PDF] Comparación de cultivos celulares bidimensionales y tridimensionales para la generación de un modelo in vitro de mesencéfalo ventral
ALP Maldonado - 2020 - ru.dgb.unam.mx
Comparación de cultivos celulares bidimensionales y tridimensionales para la generación de
un modelo in vitro de mesencéfalo Page 1 UNIVERSIDAD NACIONAL AUTÓNOMA DE …
un modelo in vitro de mesencéfalo Page 1 UNIVERSIDAD NACIONAL AUTÓNOMA DE …
[PDF][PDF] Engineering and optimising a functional in vitro model of basal ganglia circuitry
MJ Kӧse-Dunn - 2019 - keele-repository.worktribe.com
Use of iPSCs for the treatment of neurodegenerative diseases
CFM Serra - 2019 - search.proquest.com
Stem cells, due to their multi-differentiation potential, have been in these last years, a
promising and growing field of study. Since Takahashi and Yamanaka's breakthrough …
promising and growing field of study. Since Takahashi and Yamanaka's breakthrough …
[PDF][PDF] Interplay of Endoplasmic Reticulum Stress and Autophagy in Parkinson's Disease
CLAP Tavares - 2017 - run.unl.pt
Parkinson's disease (PD) is characterized by the selective loss of dopaminergic neurons of
the substantia nigra pars compacta, and by the accumulation of misfolded proteins …
the substantia nigra pars compacta, and by the accumulation of misfolded proteins …
Avaliação do efeito neuroprotetor da estimulação magnética estática em modelo in vitro da Doença de Parkinson
MC Stapenhorst - 2018 - lume.ufrgs.br
Técnicas de estimulação magnética cerebral têm sido amplamente utilizadas no tratamento
de doenças do sistema nervoso, como a doença de Parkinson (DP), mas seu real …
de doenças do sistema nervoso, como a doença de Parkinson (DP), mas seu real …